NEUE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NEUE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
NeueHealth's change in receivables for the quarter that ended in Mar. 2024 was $-532 Mil. It means NeueHealth's Accounts Receivable increased by $532 Mil from Dec. 2023 to Mar. 2024 .
NeueHealth's change in receivables for the fiscal year that ended in Dec. 2023 was $-24 Mil. It means NeueHealth's Accounts Receivable increased by $24 Mil from Dec. 2022 to Dec. 2023 .
NeueHealth's Accounts Receivable for the quarter that ended in Mar. 2024 was $40 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. NeueHealth's Days Sales Outstanding for the three months ended in Mar. 2024 was 14.87.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. NeueHealth's liquidation value for the three months ended in Mar. 2024 was $-1,204 Mil.
The historical data trend for NeueHealth's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeueHealth Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Change In Receivables | Get a 7-Day Free Trial | -0.20 | 24.63 | -32.94 | -70.39 | -24.45 |
NeueHealth Quarterly Data | |||||||||||||||||||
Dec18 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Change In Receivables | Get a 7-Day Free Trial | -827.11 | 308.97 | 239.41 | 254.28 | -531.60 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $271 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeueHealth (NYSE:NEUE) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
NeueHealth's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 39.938 | / | 245.095 | * | 91 |
= | 14.87 |
2. In Ben Graham's calculation of liquidation value, NeueHealth's accounts receivable are only considered to be worth 75% of book value:
NeueHealth's liquidation value for the quarter that ended in Mar. 2024 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 112.762 | - | 1347.162 | + | 0.75 * 39.938 | + | 0.5 * 0 |
= | -1,204 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of NeueHealth's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Mikan George Lawrence Iii | director, officer: CEO and President | 200 SW 1ST AVE, SUITE 1600, FORT LAUDERDALE FL 33301 |
Jay Matushak | officer: Chief Financial Officer | C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS MN 55437 |
Jeffrey S Cook | officer: CEO, NeueHealth | C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437 |
Jeffrey J Scherman | officer: Chief Accounting Officer | C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 1200, MINNEAPOLIS MN 55437 |
Cathy R Smith | officer: CFO & CAO | TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403 |
Jeff Michael Craig | officer: GC & CORPORATE SECRETARY | C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437 |
Manuel Kadre | director | 2020 SALZEDO STREET, SUITE 301, CORAL GABLES FL 33134 |
Jeffrey R Immelt | director | GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210 |
Nea 18 Vge Gp, Llc | 10 percent owner | C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Nea Partners 18 Vge, L.p. | 10 percent owner | C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Nea 18 Venture Growth Equity, L.p. | 10 percent owner | 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Nea 17 Gp, Llc | 10 percent owner | 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Nea Partners 17, L.p. | 10 percent owner | 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
New Enterprise Associates 17, L.p. | 10 percent owner | 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093 |
Michael A Carson | officer: CEO, Bright HealthCare | C/O BRIGHT HEALTH GROUP INC., 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437 |
From GuruFocus
By Business Wire • 08-09-2023
By GuruFocusNews GuruFocusNews • 03-29-2022
By Business Wire • 08-07-2023
By Business Wire Business Wire • 04-28-2023
By Business Wire Business Wire • 05-03-2023
By Business Wire Business Wire • 02-10-2023
By Business Wire • 11-30-2023
By Business Wire Business Wire • 04-07-2022
By Business Wire Business Wire • 07-26-2022
By Business Wire • 10-13-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.